Evidence map›Paper›PMID 25426253›Full record

ReviewWorld journal of stem cells2014

Connexin mutant embryonic stem cells and human diseases.

Kiyomasa Nishii, Yosaburo Shibata, Yasushi Kobayashi

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of stem cells, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Therapeutic strategies targeting connexins.Nature reviews. Drug discovery · 2018
    Review
  6. Article
  7. Review
  8. Article
  9. [Expression of connexin 43 gene during early dental development in zebra fish].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kiyomasa NishiiKiyomasa Nishii, Yasushi Kobayashi, Department of Anatomy and Neurobiology, National Defense Medical College, Saitama 359-8513, Japan.
Yosaburo ShibataKiyomasa Nishii, Yasushi Kobayashi, Department of Anatomy and Neurobiology, National Defense Medical College, Saitama 359-8513, Japan.
Yasushi KobayashiKiyomasa Nishii, Yasushi Kobayashi, Department of Anatomy and Neurobiology, National Defense Medical College, Saitama 359-8513, Japan.
Obayashi (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intercellular communication via gap junctions allows cells within multicellular organisms to share small molecules. The effect of such interactions has been elucidated using mouse gene knockout strategies. Although several mutations in human gap junction-encoding connexin (Cx) have been described, Cx mutants in mice do not always recapitulate the human disease. Among the 20 mouse Cxs, Cx26, Cx43, and Cx45 play roles in early cardiac or placental development, and disruption of the genes results in lethality that hampers further analyses. Embryonic stem cells (ESCs) that lack Cx43 or Cx45 have made analysis feasible in both in vitro differentiated cell cultures and in vivo chimeric tissues. The success of mouse ESCs studies is leading to the use of induced pluripotent stem cells to learn more about the pathogenesis of human Cx diseases. This review summarizes the current status of mouse Cx disruption models and ESC differentiation studies, and discusses their implication for understanding human Cx diseases.

Indexed as

ChimeraDifferentiationEmbryonic stem cellsGap junctionGenetic modelsHuman diseasesInduced pluripotent stem cells

Identifiers

PMID25426253
PMCPMC4178256
OpenAlexW1998123033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.